Crabtree GS, Chang JS (2021) Management of complications and vision loss from proliferative diabetic retinopathy. Curr DiabRep 21(9):33. https://doi.org/10.1007/s11892-021-01396-2

Article  Google Scholar 

Newman DK (2010) Surgical management of the late complications of proliferative diabetic retinopathy. Eye 24(3):441–449. https://doi.org/10.1038/eye.2009.325

Article  CAS  PubMed  Google Scholar 

Huang CH, Hsieh YT, Yang CM (2017) Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol 255(5):863–871. https://doi.org/10.1007/s00417-016-3579-4

Article  PubMed  Google Scholar 

Sulak M, Urbancic M, Petrovic MG (2018) Predicting visual outcomes of second eye vitrectomy for proliferative diabetic retinopathy. Retina 38(4):698–707. https://doi.org/10.1097/iae.0000000000001589

Article  PubMed  Google Scholar 

Hwang JC, Sharma AG, Eliott D (2013) Fellow eye vitrectomy for proliferative diabetic retinopathy in an inner city population. Br J Ophthalmol 97(3):297–301. https://doi.org/10.1136/bjophthalmol-2012-302233

Article  PubMed  Google Scholar 

Liao M, Wang X, Yu J, Meng X, Liu Y, Dong X, Li J, Brant R, Huang B, Yan H (2020) Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmol 20(1):416. https://doi.org/10.1186/s12886-020-01688-3

Article  PubMed  PubMed Central  Google Scholar 

Mikhail M, Ali-Ridha A, Chorfi S, Kapusta MA (2017) Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment. Graefes Arch Clin Exp Ophthalmol 255(2):255–261. https://doi.org/10.1007/s00417-016-3442-7

Article  PubMed  Google Scholar 

Choovuthayakorn J, Khunsongkiet P, Patikulsila D, Watanachai N, Kunavisarut P, Chaikitmongkol V, Ittipunkul N (2019) Characteristics and outcomes of pars plana vitrectomy for proliferative diabetic retinopathy patients in a limited resource tertiary center over an eight-year period. J Ophthalmol 2019:9481902. https://doi.org/10.1155/2019/9481902

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schreur V, Brouwers J, Van Huet RAC, Smeets S, Phan M, Hoyng CB, de Jong EK, Klevering BJ (2021) Long-term outcomes of vitrectomy for proliferative diabetic retinopathy. Acta Ophthalmol 99(1):83–89. https://doi.org/10.1111/aos.14482

Article  PubMed  Google Scholar 

Azad R, Sinha S, Nishant P (2021) Asymmetric diabetic retinopathy. Indian J Ophthalmol 69(11):3026–3034. https://doi.org/10.4103/ijo.IJO_1525_21

Article  PubMed  PubMed Central  Google Scholar 

Berrocal MH, Acaba-Berrocal L and Acaba AM (2022) Long-term outcomes of same patient eyes treated with pars plana vitrectomy in one eye and conventional treatment in the other for complications of proliferative diabetic retinopathy. J Clin Med 11 (18). https://doi.org/10.3390/jcm11185399

Vote BJ, Gamble GD, Polkinghorne PJ (2004) Auckland proliferative diabetic vitrectomy fellow eye study. Clin Exp Ophthalmol 32(4):397–403. https://doi.org/10.1111/j.1442-9071.2004.00845.x

Article  PubMed  Google Scholar 

Smiddy WE, Feuer W, Irvine WD, Flynn HW Jr, Blankenship GW (1995) Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes. Ophthalmology 102(11):1688–1695. https://doi.org/10.1016/s0161-6420(95)30808-1

Article  CAS  PubMed  Google Scholar 

Hsia Y, Yang CM, Hsieh YT, Wang LC (2022) Secondary full-thickness macular holes after diabetic vitrectomy: clinical manifestations and rational approaches to the treatment. J Ophthalmol 2022:3156642. https://doi.org/10.1155/2022/3156642

Article  PubMed  PubMed Central  Google Scholar 

Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW (2018) Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol 136(10):1138–1148. https://doi.org/10.1001/jamaophthalmol.2018.3255

Article  PubMed  PubMed Central  Google Scholar 

Khan R, Surya J, Rajalakshmi R, Rani PK, Anantharaman G, Gopalakrishnan M, Sen A, Desai A, Roy R, Natarajan S, Chen L, Chawla G, Behera UC, Gopal L, Muralidharan V, Sivaprasad S, Raman R (2021) Need for vitreous surgeries in proliferative diabetic retinopathy in 10-year follow-up: India Retinal Disease Study Group report no. 2. Ophthalmic Res 64(3):432–439. https://doi.org/10.1159/000512767

Article  PubMed  Google Scholar 

Ozone D, Hirano Y, Ueda J, Yasukawa T, Yoshida M, Ogura Y (2011) Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Ophthalmologica 226(2):76–80. https://doi.org/10.1159/000328407

Article  PubMed  Google Scholar 

Berrocal MH, Acaba-Berrocal L (2021) Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature. Curr Opin Ophthalmol 32(3):203–208. https://doi.org/10.1097/icu.0000000000000760

Article  PubMed  Google Scholar 

Song YS, Nagaoka T, Omae T, Yokota H, Takahashi A, Yoshida A (2016) Systemic risk factors in bilateral proliferative diabetic retinopathy requiring vitrectomy. Retina 36(7):1309–1313. https://doi.org/10.1097/iae.0000000000000886

Article  CAS  PubMed  Google Scholar 

Fassbender JM, Ozkok A, Canter H, Schaal S (2016) A comparison of immediate and delayed vitrectomy for the management of vitreous hemorrhage due to proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina 47(1):35–41. https://doi.org/10.3928/23258160-20151214-05

Article  PubMed  Google Scholar 

Bodanowitz S, Hesse L, Weinand F, Kroll P (1996) Vitrectomy in diabetic patients with a blind fellow eye. Acta Ophthalmol Scand 74(1):84–88. https://doi.org/10.1111/j.1600-0420.1996.tb00690.x

Article  CAS  PubMed  Google Scholar 

La Heij EC, Tecim S, Kessels AG, Liem AT, Japing WJ, Hendrikse F (2004) Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 242(3):210–217. https://doi.org/10.1007/s00417-003-0815-5

Article  PubMed  Google Scholar 

Lin S-J, Yeh P-T, Huang J-Y, Yang C-M (2014) Preoperative prognostic factors in vitrectomy for severe proliferative diabetic retinopathy. Taiwan J Ophthalmol 4(4):174–178. https://doi.org/10.1016/j.tjo.2014.08.005

Article  Google Scholar 

Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118(4):445–450. https://doi.org/10.1016/s0002-9394(14)75794-0

Article  CAS  PubMed  Google Scholar 

Osaadon P, Fagan XJ, Lifshitz T, Levy J (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) 28(5):510–520. https://doi.org/10.1038/eye.2014.13

Article  CAS  PubMed  Google Scholar 

Sivaprasad S, Prevost AT, Vasconcelos JC, Riddell A, Murphy C, Kelly J, Bainbridge J, Tudor-Edwards R, Hopkins D, Hykin P (2017) Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet 389(10085):2193–2203. https://doi.org/10.1016/s0140-6736(17)31193-5

Article  CAS  PubMed  Google Scholar 

Arevalo JF, Beatson B (2023) Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023. Int J Retina Vitreous 9(1):29. https://doi.org/10.1186/s40942-023-00467-8

Article  PubMed  PubMed Central  Google Scholar 

Takayama K, Someya H, Yokoyama H, Takamura Y, Morioka M, Sameshima S, Ueda T, Kitano S, Tashiro M, Sugimoto M, Kondo M, Sakamoto T, Takeuchi M (2019) Risk factors of neovascular glaucoma after 25-gauge vitrectomy for proliferative diabetic retinopathy with vitreous hemorrhage: a retrospective multicenter study. Sci Rep 9(1):14858. https://doi.org/10.1038/s41598-019-51411-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakamoto M, Hashimoto R, Yoshida I, Ubuka M, Maeno T (2018) Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol 12:2323–2329. https://doi.org/10.2147/opth.S184959

Article  PubMed  PubMed Central  Google Scholar 

Kingston EJ, Lusthaus JA (2023) Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma. Int Ophthalmol 43(8):2763–2776. https://doi.org/10.1007/s10792-023-02675-5

Article  PubMed  PubMed Central  Google Scholar